Protocol Details
Assessment and Treatment of People with Alcohol Drinking Problems
This study is currently recruiting participants.
Summary | Eligibility | Citations | Contacts
Summary
Number |
05-AA-0121 |
Sponsoring Institute |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
Recruitment Detail |
Type: Participants currently recruited/enrolled |
Referral Letter Required |
No |
Population Exclusion(s) |
Children |
Special Instructions |
Currently Not Provided |
Keywords |
Dependence; |
Recruitment Keyword(s) |
Alcohol Dependence; |
Condition(s) |
Alcoholism; |
Investigational Drug(s) |
None |
Investigational Device(s) |
None |
Intervention(s) |
None |
Supporting Site |
|
The study is open to people age 18 and older whose alcohol drinking has caused significant problems in their lives, and who desire alcoholism treatment. Detoxification will be provided if needed, and each person may participate in our alcoholism treatment program. The treatment includes group and individual counseling sessions as well as self-help meetings such as AA. Family counseling and recreational opportunities are also an important part of the treatment experience. The doctors, nurses, social workers and all of our other staff are committed to helping participants design an aftercare program that will help them leave the hospital and remain sober. Participants may also be able to attend a 12-week aftercare program in the NIAAA outpatient clinic.
Eligibility
INCLUSION CRITERIA:
Age greater than 18 years old.
Are seeking help for alcohol drinking-related problems.
EXCLUSION CRITERIA:
People who present with complicated medical problems requiring intensive medical or diagnostic management, such as:
Hypertensive emergency;
Serious GI bleeding;
Major organ or body system dysfunction such as decompensated liver disease, renal failure, myocardial ischemia, congestive heart failure or cerebrovascular disease, major endocrine problems such as uncontrolled diabetes, pancreatic or thyroid disease.
People who are infected with the Human Immunodeficiency Virus (HIV).
Serious neuro-psychiatric conditions which impair judgment or cognitive function to an extent that precludes them from providing informed consent, such as acute psychosis or severe dementia (incompetent individuals).
People who are unlikely or unable to complete the treatment program because they become or are likely to be incarcerated while on the protocol.
People who are required to receive treatment by a court of law or who are involuntarily committed to treatment.
Citations:
Contacts:
Principal Investigator |
Referral Contact |
For more information: |
| David T. George, M.D. National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institutes of Health 10 CENTER DR BG 10-CRC RM 2-2352 MSC 1540 BETHESDA MD 20892-1540 (301) 435-9385 tedg@mail.nih.gov |
Debra Hill National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institutes of Health Building 10 Room1-5300 SE 10 Center Drive Bethesda, Maryland 20892 (301) 402-2721 debbyh@mail.nih.gov |
Patient Recruitment and Public Liaison Office Building 61 10 Cloister Court Bethesda, Maryland 20892-4754 Toll Free: 1-800-411-1222 TTY: 301-594-9774 (local),1-866-411-1010 (toll free) Fax: 301-480-9793 prpl@mail.cc.nih.gov |
Clinical Trials Number:
NCT00106093
QUESTIONS?
Contact the Patient Recruitment and Public Liaison Office for:
- Details on how to participate in a study
- Details on how to refer a patient to a study
NIH Clinical Studies Information Request
Contact the Office of Communications for:
- General information about the NIH Clinical Center
Contact the Department Clinical Research Informatics, (DCRI) for:
- Technical questions about Adobe Acrobat and the PDF format
- Technical questions about this web server




